{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:53:40Z","timestamp":1790970820539,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study evaluates the effectiveness and clinical outcomes of superselective transarterial embolization (TAE) using Gelfoam particles for the management of intractable hematuria. Twenty patients (7 men and 13 women; mean age 70.65 years [range, 47\u201386 years]) with intractable hematuria who underwent superselective TAE between April 2014 and July 2021 were included in this retrospective study. Embolization of the vesical arteries was performed in all 20 patients using Gelfoam particles. Patients were divided into 2 groups based on the cause of hematuria: radiation cystitis and cancer bleeding. Retrospective evaluations of patient demographics, technical and clinical success rates, hematuria grade, serum hemoglobin (Hb) level (g\/dL), complications, and mortality rate were performed. Hematuria was graded as follows: grade I (none); grade II (microscopic); grade III (macroscopic, without transfusion); grade IV (macroscopic, with intermittent transfusion); and grade V (macroscopic, with daily transfusion). The Wilcoxon signed-rank test was performed to compare the pre- and post-embolization hematuria grades and serum Hb levels within each group. The technical success rate was 100% (20\/20 patients), and the overall clinical success rate was 85% (17\/20 patients). The overall mean serum Hb level increased from 7.57 to 11.30 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), and the overall mean hematuria grade decreased from 4 to 2 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001) after TAE. In the radiation cystitis group, the clinical success rate was 90% (10\/11 patients), the mean serum Hb level increased from 7.8 to 12.2 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.004), and the mean hematuria grade decreased from 4 to 1.6 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.004). In the cancer bleeding group, the clinical success rate was 77% (7\/9 patients), the mean serum Hb level increased from 7.3 to 10.2 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.021), and the mean hematuria grade decreased from 4 to 2.4 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.017). Minor complications were noted in 8\/20 (40%) cases, notably post-embolization syndrome, managed conservatively. No major complications occurred in either group. Eleven deaths occurred during the mean follow-up period of 9.6\u2005\u00b1\u200531 months, and none of the deaths were procedure-related. Superselective TAE with Gelfoam particles is a feasible, effective, and safe treatment for intractable hematuria, both in patients with radiation cystitis and cancer bleeding.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050880","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:00:47Z","timestamp":1790967647000},"page":"e50880","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Superselective transarterial embolization of intractable hematuria using Gelfoam particles"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-5128","authenticated-orcid":false,"given":"Jin Ho","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Radiology, Kosin University Gospel Hospital, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7044-9311","authenticated-orcid":false,"given":"Su Hwan","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kosin University Gospel Hospital, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1229-5745","authenticated-orcid":false,"given":"Jung Gu","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kosin University Gospel Hospital, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-8883","authenticated-orcid":false,"given":"Eun Mi","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5625-0912","authenticated-orcid":false,"given":"Jin Hyuk","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kosin University Gospel Hospital, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3711-213X","authenticated-orcid":false,"given":"Hanggoo","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0096-0664","authenticated-orcid":false,"given":"Taek Yong","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Kosin University Gospel Hospital, Busan, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-4212","authenticated-orcid":false,"given":"Jong Hyouk","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kosin University Gospel Hospital, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42155-020-00188-1","article-title":"Long-term results of super-selective trans-catheter embolization of the vesical arteries for the treatment of intractable bladder haematuria.","volume":"3","author":"Tsitskari","year":"2020","journal-title":"CVIR Endovasc"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.diii.2015.06.020","article-title":"The short-and long-term effectiveness of transcatheter arterial embolization in patients with intractable hematuria.","volume":"97","author":"Korkmaz","year":"2016","journal-title":"Diagn Interventional Imaging"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.diii.2014.03.008","article-title":"Current role of transcatheter arterial embolization for bladder and prostate hemorrhage.","volume":"95","author":"Loffroy","year":"2014","journal-title":"Diagn Interventional Imaging"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s00345-018-2604-0","article-title":"Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis.","volume":"37","author":"Mohan","year":"2019","journal-title":"World J Urol"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1464-410X.2009.09192.x","article-title":"Intractable haematuria: long-term results after selective embolization of the internal iliac arteries.","volume":"106","author":"Liguori","year":"2010","journal-title":"BJU Int"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.aju.2018.01.004","article-title":"Selective embolisation for intractable bladder haemorrhages: a systematic review of the literature.","volume":"16","author":"Taha","year":"2018","journal-title":"Arab J Urol"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1464-410x.2000.00900.x","article-title":"The management of intractable haematuria.","volume":"86","author":"Choong","year":"2000","journal-title":"BJU Int"},{"key":"R8-20261002"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"476.e1","DOI":"10.1016\/j.jvir.2020.10.022","article-title":"Society of interventional radiology quality improvement standards for percutaneous transcatheter embolization.","volume":"32","author":"Dariushnia","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jvir.2009.04.048","article-title":"Embolotherapy for lower urinary tract hemorrhage.","volume":"20","author":"Prasad","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1464-410X.2003.04328.x","article-title":"Therapeutic transcatheter arterial embolization in the management of intractable haemorrhage from pelvic urological malignancies: preliminary experience and long-term follow-up.","volume":"92","author":"Nabi","year":"2003","journal-title":"BJU Int"},{"key":"R12-20261002","first-page":"595","article-title":"Persistent gluteal pain after embolization of the hypogastric arteries. An unexpected complication.","volume":"89","author":"Greenstein","year":"1983","journal-title":"J Urol (Paris)"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacbts.2018.01.014","article-title":"Radiation-induced endothelial vascular injury: a review of possible mechanisms.","volume":"3","author":"Venkatesulu","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2214\/AJR.14.12480","article-title":"A case-based approach to common embolization agents used in vascular interventional radiology.","volume":"203","author":"Medsinge","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0028-1085930","article-title":"An overview of embolic agents.","volume":"25","author":"Vaidya","year":"2008","journal-title":"Semin Intervent Radiol"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.juro.2010.01.003","article-title":"Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage.","volume":"183","author":"Delgal","year":"2010","journal-title":"J Urol"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/157016109787455617","article-title":"Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues.","volume":"7","author":"Loffroy","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/jfb8020012","article-title":"Endovascular embolization by transcatheter delivery of particles: past, present, and future.","volume":"8","author":"Sheth","year":"2017","journal-title":"J Funct Biomater"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3348\/kjr.2015.16.1.133","article-title":"Evaluation of arterial impairment after experimental gelatin sponge embolization in a rabbit renal model.","volume":"16","author":"Oh","year":"2015","journal-title":"Korean J Radiol"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1442-2042.2005.01074.x","article-title":"Superselective embolization of bladder arteries in the treatment of intractable bladder haemorrhage.","volume":"12","author":"De Berardinis","year":"2005","journal-title":"Int J Urol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:00:49Z","timestamp":1790967649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050880"}},"subtitle":["A retrospective single-center study"],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":20,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050880","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"2026-03-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}